Late HIV Diagnosis: Predictors, Costs, Consequences, And Solutions. Late HIV Diagnosis: Predictors, Costs, Consequences, And Solutions.

Late HIV Diagnosis: Predictors, Costs, Consequences, And Solutions‪.‬

Research Initiative/Treatment Action! 2011, Spring, 16, 1

    • $5.99
    • $5.99

Publisher Description

More than a million people in the United States have HIV infection, and fewer than 1 in 5 has an undetectable viral load. (1) That eye-popping estimate--based on a synthesis of recently published data--explains why HIV incidence stands at a staggering 56,000 yearly in the United States, and has since the turn of the millennium. (2) You don't have to look far for the reasons behind these galling tallies: A perdurably high proportion of HIV-positive people remains untested; those who test positive sometimes never see the inside of an HIV clinic; and those who enter care drift away in waves. This triple threat to steady treatment--late diagnosis, sluggish linkage to care, and fleeting retention---conspire to keep the collective viral load so high that further HIV transmission is a foregone conclusion.

GENRE
Health, Mind & Body
RELEASED
2011
March 22
LANGUAGE
EN
English
LENGTH
50
Pages
PUBLISHER
The Center for AIDS: Hope & Remembrance Project
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
261.9
KB

More Books by Research Initiative/Treatment Action!

Body Shape Changes: Where are We? Body Shape Changes: Where are We?
2006
The Hepatitis C Drug Development Pipeline (Hcv Pipeline) The Hepatitis C Drug Development Pipeline (Hcv Pipeline)
2004
Cancer in the Hiv-Infected Population (Data Review) Cancer in the Hiv-Infected Population (Data Review)
2003
An Overview of the Biology and Viral Pathogenesis of Lymphoproliferative Disorders in Hiv-Infected Patients (Data Review) An Overview of the Biology and Viral Pathogenesis of Lymphoproliferative Disorders in Hiv-Infected Patients (Data Review)
2003
Biomedical Prevention: Has Its Time Now Come?(In Context) Biomedical Prevention: Has Its Time Now Come?(In Context)
2007
The Use of Antiretroviral Therapy in Patients Undergoing Treatment for Hiv-Related Neoplastic Disease (Clinical Considerations) The Use of Antiretroviral Therapy in Patients Undergoing Treatment for Hiv-Related Neoplastic Disease (Clinical Considerations)
2003